DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity

Abstract

Gleevec is a potent inhibitor of Abl tyrosine kinase but not of the highly homologous c-Src kinase. Because the ligand binds to an inactive form of the protein in which an Asp-Phe-Gly structural motif along the activation loop adopts a so-called DFG-out conformation, it was suggested that binding specificity was controlled by a “conformational selection” mechanism. In this context, the binding affinity displayed by the kinase inhibitor G6G poses an intriguing challenge. Although it possesses a chemical core very similar to that of Gleevec, G6G is a potent inhibitor of both Abl and c-Src kinases. Both inhibitors bind to the DFG-out conformation of the kinases, which seems to be in contradiction with the conformational selection mechanism. To address this issue and display the hidden thermodynamic contributions affecting the binding selectivity, molecular dynamics free energy simulations with explicit solvent molecules were carried out. Relative to Gleevec, G6G forms highly favorable van der Waals dispersive interactions upon binding to the kinases via its triazine functional group, which is considerably larger than the corresponding pyridine moiety in Gleevec. Upon binding of G6G to c-Src, these interactions offset the unfavorable free energy cost of the DFG-out conformation. When binding to Abl, however, G6G experiencesmore » an unfavorable free energy penalty due to steric clashes with the phosphate-binding loop, yielding an overall binding affinity that is similar to that of Gleevec. Such steric clashes are absent when G6G binds to c-Src, due to the extended conformation of the phosphate-binding loop.« less

Authors:
 [1];  [1];  [1];  [1]
  1. Univ. of Chicago, Chicago, IL (United States). Dept. of Biochemistry and Molecular Biology.
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
National Cancer Institute of the National Institutes of Health (NIH); National Science Foundation (NSF)
OSTI Identifier:
1214160
Grant/Contract Number:  
AC02-06CH11357
Resource Type:
Accepted Manuscript
Journal Name:
Journal of the American Chemical Society
Additional Journal Information:
Journal Volume: 136; Journal Issue: 42; Journal ID: ISSN 0002-7863
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Lin, Yen -Lin, Meng, Yilin, Huang, Lei, and Roux, Benoît. Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity. United States: N. p., 2014. Web. doi:10.1021/ja504146x.
Lin, Yen -Lin, Meng, Yilin, Huang, Lei, & Roux, Benoît. Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity. United States. https://doi.org/10.1021/ja504146x
Lin, Yen -Lin, Meng, Yilin, Huang, Lei, and Roux, Benoît. Wed . "Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity". United States. https://doi.org/10.1021/ja504146x. https://www.osti.gov/servlets/purl/1214160.
@article{osti_1214160,
title = {Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity},
author = {Lin, Yen -Lin and Meng, Yilin and Huang, Lei and Roux, Benoît},
abstractNote = {Gleevec is a potent inhibitor of Abl tyrosine kinase but not of the highly homologous c-Src kinase. Because the ligand binds to an inactive form of the protein in which an Asp-Phe-Gly structural motif along the activation loop adopts a so-called DFG-out conformation, it was suggested that binding specificity was controlled by a “conformational selection” mechanism. In this context, the binding affinity displayed by the kinase inhibitor G6G poses an intriguing challenge. Although it possesses a chemical core very similar to that of Gleevec, G6G is a potent inhibitor of both Abl and c-Src kinases. Both inhibitors bind to the DFG-out conformation of the kinases, which seems to be in contradiction with the conformational selection mechanism. To address this issue and display the hidden thermodynamic contributions affecting the binding selectivity, molecular dynamics free energy simulations with explicit solvent molecules were carried out. Relative to Gleevec, G6G forms highly favorable van der Waals dispersive interactions upon binding to the kinases via its triazine functional group, which is considerably larger than the corresponding pyridine moiety in Gleevec. Upon binding of G6G to c-Src, these interactions offset the unfavorable free energy cost of the DFG-out conformation. When binding to Abl, however, G6G experiences an unfavorable free energy penalty due to steric clashes with the phosphate-binding loop, yielding an overall binding affinity that is similar to that of Gleevec. Such steric clashes are absent when G6G binds to c-Src, due to the extended conformation of the phosphate-binding loop.},
doi = {10.1021/ja504146x},
journal = {Journal of the American Chemical Society},
number = 42,
volume = 136,
place = {United States},
year = {Wed Oct 22 00:00:00 EDT 2014},
month = {Wed Oct 22 00:00:00 EDT 2014}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 41 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Protein Kinase Inhibitors: Insights into Drug Design from Structure
journal, March 2004


Predicting Kinase Selectivity Profiles Using Free-Wilson QSAR Analysis
journal, August 2008

  • Sciabola, Simone; Stanton, Robert V.; Wittkopp, Sarah
  • Journal of Chemical Information and Modeling, Vol. 48, Issue 9
  • DOI: 10.1021/ci800138n

Attacking cancer at its foundation
journal, October 2009


c-Src Binds to the Cancer Drug Imatinib with an Inactive Abl/c-Kit Conformation and a Distributed Thermodynamic Penalty
journal, March 2007


Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
journal, March 2009


The development of imatinib as a therapeutic agent for chronic myeloid leukemia
journal, April 2005


Explaining why Gleevec is a specific and potent inhibitor of Abl kinase
journal, January 2013

  • Lin, Y. -L.; Meng, Y.; Jiang, W.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 5
  • DOI: 10.1073/pnas.1214330110

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
journal, September 2000


The Different Flexibility of c-Src and c-Abl Kinases Regulates the Accessibility of a Druggable Inactive Conformation
journal, January 2012

  • Lovera, Silvia; Sutto, Ludovico; Boubeva, Ralitza
  • Journal of the American Chemical Society, Vol. 134, Issue 5
  • DOI: 10.1021/ja210751t

Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation
journal, October 2008


Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases
journal, March 2010

  • Aleksandrov, Alexey; Simonson, Thomas
  • Journal of Biological Chemistry, Vol. 285, Issue 18
  • DOI: 10.1074/jbc.M110.109660

Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors
journal, February 2007

  • Liao, Jeffrey Jie-Lou
  • Journal of Medicinal Chemistry, Vol. 50, Issue 3
  • DOI: 10.1021/jm0608107

Understanding the Impact of the P-loop Conformation on Kinase Selectivity
journal, May 2011

  • Guimarães, Cristiano R. W.; Rai, Brajesh K.; Munchhof, Michael J.
  • Journal of Chemical Information and Modeling, Vol. 51, Issue 6
  • DOI: 10.1021/ci200153c

Efficient computation of absolute free energies of binding by computer simulations. Application to the methane dimer in water
journal, September 1988

  • Jorgensen, William L.; Buckner, J. Kathleen; Boudon, Stephane
  • The Journal of Chemical Physics, Vol. 89, Issue 6
  • DOI: 10.1063/1.454895

All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
journal, April 1998

  • MacKerell, A. D.; Bashford, D.; Bellott, M.
  • The Journal of Physical Chemistry B, Vol. 102, Issue 18
  • DOI: 10.1021/jp973084f

Improved Treatment of the Protein Backbone in Empirical Force Fields
journal, January 2004

  • MacKerell, Alexander D.; Feig, Michael; Brooks, Charles L.
  • Journal of the American Chemical Society, Vol. 126, Issue 3
  • DOI: 10.1021/ja036959e

Comparison of simple potential functions for simulating liquid water
journal, July 1983

  • Jorgensen, William L.; Chandrasekhar, Jayaraman; Madura, Jeffry D.
  • The Journal of Chemical Physics, Vol. 79, Issue 2
  • DOI: 10.1063/1.445869

Automated Force Field Parameterization for Nonpolarizable and Polarizable Atomic Models Based on Ab Initio Target Data
journal, July 2013

  • Huang, Lei; Roux, Benoît
  • Journal of Chemical Theory and Computation, Vol. 9, Issue 8
  • DOI: 10.1021/ct4003477

Acid−Base Profiling of Imatinib (Gleevec) and Its Fragments
journal, December 2004

  • Szakács, Zoltán; Béni, Szabolcs; Varga, Zoltán
  • Journal of Medicinal Chemistry, Vol. 48, Issue 1
  • DOI: 10.1021/jm049546c

Polar hydrogen positions in proteins: Empirical energy placement and neutron diffraction comparison
journal, January 1988

  • Brünger, Axel T.; Karplus, Martin
  • Proteins: Structure, Function, and Genetics, Vol. 4, Issue 2
  • DOI: 10.1002/prot.340040208

CHARMM: The biomolecular simulation program
journal, July 2009

  • Brooks, B. R.; Brooks, C. L.; Mackerell, A. D.
  • Journal of Computational Chemistry, Vol. 30, Issue 10
  • DOI: 10.1002/jcc.21287

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
journal, July 1983

  • Brooks, Bernard R.; Bruccoleri, Robert E.; Olafson, Barry D.
  • Journal of Computational Chemistry, Vol. 4, Issue 2
  • DOI: 10.1002/jcc.540040211

Scalable molecular dynamics with NAMD
journal, January 2005

  • Phillips, James C.; Braun, Rosemary; Wang, Wei
  • Journal of Computational Chemistry, Vol. 26, Issue 16, p. 1781-1802
  • DOI: 10.1002/jcc.20289

Particle mesh Ewald: An N ⋅log( N ) method for Ewald sums in large systems
journal, June 1993

  • Darden, Tom; York, Darrin; Pedersen, Lee
  • The Journal of Chemical Physics, Vol. 98, Issue 12
  • DOI: 10.1063/1.464397

Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes
journal, March 1977

  • Ryckaert, Jean-Paul; Ciccotti, Giovanni; Berendsen, Herman J. C.
  • Journal of Computational Physics, Vol. 23, Issue 3
  • DOI: 10.1016/0021-9991(77)90098-5

Calculation of Standard Binding Free Energies:  Aromatic Molecules in the T4 Lysozyme L99A Mutant
journal, July 2006

  • Deng, Yuqing; Roux, Benoît
  • Journal of Chemical Theory and Computation, Vol. 2, Issue 5
  • DOI: 10.1021/ct060037v

Computation of binding free energy with molecular dynamics and grand canonical Monte Carlo simulations
journal, March 2008

  • Deng, Yuqing; Roux, Benoît
  • The Journal of Chemical Physics, Vol. 128, Issue 11
  • DOI: 10.1063/1.2842080

Absolute Binding Free Energy Calculations Using Molecular Dynamics Simulations with Restraining Potentials
journal, October 2006


Absolute Binding Free Energy Calculations of Sparsomycin Analogs to the Bacterial Ribosome
journal, July 2010

  • Ge, Xiaoxia; Roux, Benoît
  • The Journal of Physical Chemistry B, Vol. 114, Issue 29
  • DOI: 10.1021/jp100579y

Computational Analysis of the Binding Specificity of Gleevec to Abl, c-Kit, Lck, and c-Src Tyrosine Kinases
journal, September 2013

  • Lin, Yen-Lin; Roux, Benoît
  • Journal of the American Chemical Society, Vol. 135, Issue 39
  • DOI: 10.1021/ja405939x

Role of Repulsive Forces in Determining the Equilibrium Structure of Simple Liquids
journal, June 1971

  • Weeks, John D.; Chandler, David; Andersen, Hans C.
  • The Journal of Chemical Physics, Vol. 54, Issue 12
  • DOI: 10.1063/1.1674820

Computation of Absolute Hydration and Binding Free Energy with Free Energy Perturbation Distributed Replica-Exchange Molecular Dynamics
journal, August 2009

  • Jiang, Wei; Hodoscek, Milan; Roux, Benoît
  • Journal of Chemical Theory and Computation, Vol. 5, Issue 10
  • DOI: 10.1021/ct900223z

Free Energy Perturbation Hamiltonian Replica-Exchange Molecular Dynamics (FEP/H-REMD) for Absolute Ligand Binding Free Energy Calculations
journal, July 2010

  • Jiang, Wei; Roux, Benoît
  • Journal of Chemical Theory and Computation, Vol. 6, Issue 9
  • DOI: 10.1021/ct1001768

Interfacing Q-Chem and CHARMM to perform QM/MM reaction path calculations: Interfacing Q-Chem and CHARMM to Perform QM/MM Reaction Path Calculations
journal, March 2007

  • Woodcock, H. Lee; Hodošček, Milan; Gilbert, Andrew T. B.
  • Journal of Computational Chemistry, Vol. 28, Issue 9
  • DOI: 10.1002/jcc.20587

Exploring the quantum mechanical/molecular mechanical replica path method: a pathway optimization of the chorismate to prephenate Claisen rearrangement catalyzed by chorismate mutase
journal, April 2003

  • Lee Woodcock, H.; Hodošček, Milan; Sherwood, Paul
  • Theoretical Chemistry Accounts: Theory, Computation, and Modeling (Theoretica Chimica Acta), Vol. 109, Issue 3
  • DOI: 10.1007/s00214-002-0421-3

Calculation of absolute protein-ligand binding free energy from computer simulations
journal, May 2005

  • Woo, H. -J.; Roux, B.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 19
  • DOI: 10.1073/pnas.0409005102

THE weighted histogram analysis method for free-energy calculations on biomolecules. I. The method
journal, October 1992

  • Kumar, Shankar; Rosenberg, John M.; Bouzida, Djamal
  • Journal of Computational Chemistry, Vol. 13, Issue 8
  • DOI: 10.1002/jcc.540130812

Extension to the weighted histogram analysis method: combining umbrella sampling with free energy calculations
journal, March 2001


Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
journal, June 2009

  • Lee, Tai-Sung; Potts, Steven; Albitar, Maher
  • Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Issue 2
  • DOI: 10.2174/157489209788452867

Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations
journal, January 2008

  • Lee, Tai-Sung; Potts, Steven J.; Kantarjian, Hagop
  • Cancer, Vol. 112, Issue 8
  • DOI: 10.1002/cncr.23355

Computations of Standard Binding Free Energies with Molecular Dynamics Simulations
journal, February 2009

  • Deng, Yuqing; Roux, Benoît
  • The Journal of Physical Chemistry B, Vol. 113, Issue 8
  • DOI: 10.1021/jp807701h

Histone Methylation-Dependent Mechanisms Impose Ligand Dependency for Gene Activation by Nuclear Receptors
journal, February 2007


Protein Kinase−Inhibitor Database: Structural Variability of and Inhibitor Interactions with the Protein Kinase P-Loop
journal, September 2010

  • Patel, Ronak Y.; Doerksen, Robert J.
  • Journal of Proteome Research, Vol. 9, Issue 9
  • DOI: 10.1021/pr100662s

Scalable molecular dynamics with NAMD
journal, January 2005

  • Phillips, James C.; Braun, Rosemary; Wang, Wei
  • Journal of Computational Chemistry, Vol. 26, Issue 16, p. 1781-1802
  • DOI: 10.1002/jcc.20289

A molecular mechanics model for imatinib and imatinib:kinase binding
journal, January 2009

  • Aleksandrov, Alexey; Simonson, Thomas
  • Journal of Computational Chemistry
  • DOI: 10.1002/jcc.21442

Polar hydrogen positions in proteins: Empirical energy placement and neutron diffraction comparison
journal, January 1988

  • Brünger, Axel T.; Karplus, Martin
  • Proteins: Structure, Function, and Genetics, Vol. 4, Issue 2
  • DOI: 10.1002/prot.340040208

Visualizing the Histone Code on LSD1
journal, February 2007


c-Src Binds to the Cancer Drug Imatinib with an Inactive Abl/c-Kit Conformation and a Distributed Thermodynamic Penalty
journal, March 2007


The statistical-thermodynamic basis for computation of binding affinities: a critical review
journal, March 1997


Free Energy Perturbation Hamiltonian Replica-Exchange Molecular Dynamics (FEP/H-REMD) for Absolute Ligand Binding Free Energy Calculations
journal, July 2010

  • Jiang, Wei; Roux, Benoît
  • Journal of Chemical Theory and Computation, Vol. 6, Issue 9
  • DOI: 10.1021/ct1001768

Improved Treatment of the Protein Backbone in Empirical Force Fields
journal, January 2004

  • MacKerell, Alexander D.; Feig, Michael; Brooks, Charles L.
  • Journal of the American Chemical Society, Vol. 126, Issue 3
  • DOI: 10.1021/ja036959e

Acid−Base Profiling of Imatinib (Gleevec) and Its Fragments
journal, December 2004

  • Szakács, Zoltán; Béni, Szabolcs; Varga, Zoltán
  • Journal of Medicinal Chemistry, Vol. 48, Issue 1
  • DOI: 10.1021/jm049546c

Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors
journal, February 2007

  • Liao, Jeffrey Jie-Lou
  • Journal of Medicinal Chemistry, Vol. 50, Issue 3
  • DOI: 10.1021/jm0608107

Computations of Standard Binding Free Energies with Molecular Dynamics Simulations
journal, February 2009

  • Deng, Yuqing; Roux, Benoît
  • The Journal of Physical Chemistry B, Vol. 113, Issue 8
  • DOI: 10.1021/jp807701h

Protein Kinase−Inhibitor Database: Structural Variability of and Inhibitor Interactions with the Protein Kinase P-Loop
journal, September 2010

  • Patel, Ronak Y.; Doerksen, Robert J.
  • Journal of Proteome Research, Vol. 9, Issue 9
  • DOI: 10.1021/pr100662s

Attacking cancer at its foundation
journal, October 2009


Computation of binding free energy with molecular dynamics and grand canonical Monte Carlo simulations
journal, March 2008

  • Deng, Yuqing; Roux, Benoît
  • The Journal of Chemical Physics, Vol. 128, Issue 11
  • DOI: 10.1063/1.2842080

Calculation of absolute protein-ligand binding free energy from computer simulations
journal, May 2005

  • Woo, H. -J.; Roux, B.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 19
  • DOI: 10.1073/pnas.0409005102

Explaining why Gleevec is a specific and potent inhibitor of Abl kinase
journal, January 2013

  • Lin, Y. -L.; Meng, Y.; Jiang, W.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 5
  • DOI: 10.1073/pnas.1214330110

Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
journal, December 2006

  • Cowan-Jacob, Sandra W.; Fendrich, Gabriele; Floersheimer, Andreas
  • Acta Crystallographica Section D Biological Crystallography, Vol. 63, Issue 1
  • DOI: 10.1107/s0907444906047287

Protein Kinase Inhibitors: Insights into Drug Design from Structure
journal, March 2004


Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia
journal, December 2009


Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
journal, January 2000

  • Druker, Brian J.; Lydon, Nicholas B.
  • Journal of Clinical Investigation, Vol. 105, Issue 1
  • DOI: 10.1172/jci9083

The development of imatinib as a therapeutic agent for chronic myeloid leukemia
journal, April 2005


Works referencing / citing this record:

Comparing alchemical and physical pathway methods for computing the absolute binding free energy of charged ligands
journal, January 2018

  • Deng, Nanjie; Cui, Di; Zhang, Bin W.
  • Physical Chemistry Chemical Physics, Vol. 20, Issue 25
  • DOI: 10.1039/c8cp01524d

Computational study on the selective inhibition mechanism of MS402 to the first and second bromodomains of BRD4
journal, November 2018

  • Wang, Qianqian; Li, Ying; Xu, Jiahui
  • Proteins: Structure, Function, and Bioinformatics, Vol. 87, Issue 1
  • DOI: 10.1002/prot.25611

Classical molecular dynamics and metadynamics simulations decipher the mechanism of CBP30 selectively inhibiting CBP/p300 bromodomains
journal, January 2018

  • Wang, Qianqian; An, Xiaoli; Xu, Jiahui
  • Organic & Biomolecular Chemistry, Vol. 16, Issue 35
  • DOI: 10.1039/c8ob01526k

Evolution and intelligent design in drug development
journal, May 2015

  • Agafonov, Roman V.; Wilson, Christopher; Kern, Dorothee
  • Frontiers in Molecular Biosciences, Vol. 2
  • DOI: 10.3389/fmolb.2015.00027